News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
ProMetic Life Sciences Inc. Reports Positive Pre-Clinical Data for PBI-1402 in Anemia Related to Renal Failure
November 1, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MONTREAL, QUEBEC--(Marketwire - November 01, 2007) - ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") announced today positive pre-clinical results for PBI-1402, the Company's lead compound for treating anemia.
Twitter
LinkedIn
Facebook
Email
Print
Preclinical
MORE ON THIS TOPIC
Leadership
Vaxart seeks shareholder support as battle over stock split brews
May 21, 2026
·
2 min read
·
Tristan Manalac
Rare diseases
BioMarin bounces back as Voxzogo performs ‘bigger than expected’ in new indication
May 21, 2026
·
2 min read
·
Tristan Manalac
Insights
Inside Germany’s biotech capital infrastructure and innovation engine
May 21, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Deals
Lilly and Engage Bio tie the knot with $202M acquisition
May 20, 2026
·
2 min read
·
Gabrielle Masson
